The hippocampus in neurodegenerative disease

Frontiers of Neurology and Neuroscience

Volumn 34, Issue , 2014, Pages 95-108

  Moodley, K K ^a   Chan, D ^a,b  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; FLUORODEOXYGLUCOSE F 18; N METHYL DEXTRO ASPARTIC ACID; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; ASYMPTOMATIC DISEASE; BRAIN FUNCTION; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFORMATIONAL TRANSITION; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; ENTORHINAL CORTEX; EPISODIC MEMORY; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE FREQUENCY; GENETIC ASSOCIATION; HIPPOCAMPAL SCLEROSIS; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; MEDIAL TEMPORAL LOBE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROFIBRILLARY TANGLE; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENILE PLAQUE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; DEGENERATIVE DISEASE; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; HIPPOCAMPUS; HUMANS; NEURODEGENERATIVE DISEASES; PLAQUE, AMYLOID;

EID: 84922013349     PISSN: 16604431     EISSN: 16622804     Source Type: Book Series    
DOI: 10.1159/000356430     Document Type: Article

References (30)

1. Schott JM, Fox NC, Frost C, Scahill RI, Janssen JC, Chan D, Jenkins RR, Rossor MN: Assessing the onset of structural change in familial Alzheimer's disease. Ann Neurol 2003; 53: 181-188.
2. Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, Mehta PD, Buxbaum J, Haroutunian V, Nixon RA: Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging 2004; 25: 1263-1272.
3. Lesne SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA, Ashe KH: Brain amyloid oligomers in ageing and Alzheimer's disease. Brain 2013; 136: 1383-1398.
4. Thal DR, Rub U, Orantes M, Braak H: Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002; 58: 1791-1800.
5. Cacucci F, Yi M, Wills TJ, Chapman P, O'Keefe J: Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model. Proc Natl Acad Sci USA 2008; 105: 7863-7868.
6. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR: Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 1986; 20: 472-481.
7. Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, Duff K: Trans-synaptic spread of tau pathology in vivo. PLoS One 2012; 7:e31302.
8. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
9. Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP, Morrison JH, Gold G, Hof PR: Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003; 60: 1495-1500.
10. Tanzi RE, Bertram L: New frontiers in Alzheimer's disease genetics. Neuron 2001; 32: 181-184.
11. Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256: 184-185.
12. Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham R, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jonsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K: A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 2012; 488: 96-99.
13. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 270-279.
14. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263-269.
15. Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P: Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 2010; 9: 1118-1127.
16. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC: Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012; 367: 795-804.
17. Pengas G, Patterson K, Arnold RJ, Bird CM, Burgess N, Nestor PJ: Lost and found: bespoke memory testing for Alzheimer's disease and semantic dementia. J Alzheimers Dis 2010; 21: 1347-1365.
18. Bird CM, Chan D, Hartley T, Pijnenburg YA, Rossor MN, Burgess N: Topographical short-term memory differentiates Alzheimer's disease from frontotemporal lobar degeneration. Hippocampus 2009; 20: 1154-1169.
19. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
20. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR: The Addenbrooke's Cognitive Examination Revised (ACE-R): A brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21: 1078-1085.
21. Scheltens P, Fox N, Barkhof F, De Carli C: Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 2002; 1: 13-21.
22. Jack CR, Petersen RC, Xu YC, Waring SC, O'Brien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E: Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997; 49: 786-794.
23. Chan D, Janssen JC, Whitwell JL, Watt HC, Jenkins R, Frost C, Rossor MN, Fox NC: Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet 2003; 362: 1121-1122.
24. Mosconi L: Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease-FDGPET studies in MCI and AD. Eur J Nucl Med Mol Imaging 2005; 32: 486-510.
25. Greicius MD, Srivastava G, Reiss AL, Menon V: Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 2004; 101: 4637-4642.
26. O'Brien JL, O'Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC, Sperling RA: Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology 2010; 74: 1969-1976.
27. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang G-F, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B: Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306-319.
28. Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL, Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group: Amyloid deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. Lancet Neurol 2013; 12: 357-367.
29. Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Carrillo MC, Hartley DM, Hedrick S, Pappas V, Thies WH: Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimers Dement 2013; 9:e1-e16.
30. McKeith IG: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 2006; 9: 417-423.